November 02, 2016
Kite Pharma to Report Third Quarter 2016 Financial Results on November 9, 2016
Conference Call and Webcast Scheduled for 8:30 AM PT/11:30 AM ET
SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will report third quarter 2016 financial results on Wednesday, November 9, 2016, prior to the open of the market. The announcement will be followed by a live audio webcast and conference call at 8:30 a.m. Pacific Time/11:30 a.m. Eastern Time.
The webcast will be made available on the Company's website at www.kitepharma.com under the Investors tab in the Events and Presentations section. Following the live audio webcast, a replay will be available on the Company's website for approximately 30 days.
Live (U.S. / Canada): 1 (888) 771-4371
Live (International): 1 (847) 585-4405
Confirmation number: 43463182
About Kite Pharma
Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161102005590/en/
Kite Pharma, Inc.
SVP, Corporate Communications & Investor Relations
VP, Investor Relations
Source: Kite Pharma, Inc.
News Provided by Acquire Media